Human Plasma Paraoxonase 1 (PON1) Arylesterase Activity During Aging: Correlation with Susceptibility of LDL Oxidation

Archives of Medical Research

Volumn 43, Issue 6, 2012, Pages 438-443

  Mehdi, Mohammad Murtaza ^a   Rizvi, Syed Ibrahim ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Aging; Low density lipoproteins; Oxidative stress; Paraoxonase 1; Plasma

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; AGING; ANTIOXIDANT ACTIVITY; ARTICLE; DISEASE PREDISPOSITION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OXIDATION; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AGING; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 84867860042     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.08.012     Document Type: Article

References (46)

1. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956, 11:298-300.
2. McCord J.M., Fridovich I. Superoxide dismutase. An enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 1969, 244:6049-6055.
3. Golubev A.G. The other side of metabolism: a review. Biochemistry 1996, 61:1443-1460.
4. Smith B.L., Martin J.A., Ventura S.J. Births and deaths: preliminary data for July 1997 June 1998. Natl Vital Stat Rep 1999, 47:1-32.
5. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
6. Gackowski D., Kruszewski M., Jawien A., et al. Further evidence that oxidative stress may be a risk factor responsible for the development of atherosclerosis. Free Radic Biol Med 2001, 31:542-547.
7. Hamed S.A., Hamed E.A., Hamdy R., et al. Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res 2007, 74:183-192.
8. Katakami N., Sakamoto K., Kaneto H., et al. Combined effect of oxidative stress-related gene polymorphisms on atherosclerosis. Biochem Biophys Res Commun 2009, 379:861-865.
9. Reaven P.D., Napoli C., Merat S., et al. Lipoprotein modification and atherosclerosis in aging. Exp Gerontol 2000, 34:527-537.
10. Miller N.E., La Ville A., Crook D. Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit. Nature 1985, 314:109-111.
11. Jansen K.L., Cole T.B., Park S.S., et al. Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds. Toxicol Appl Pharmacol 2009, 236:142-153.
12. Khalil A., Wagner J.R., Lacombe G., et al. Increased susceptibility of low-density lipoprotein (LDL) to oxidation by gamma-radiolysis with age. FEBS Lett 1996, 392:45-48.
13. Khalil A., Jay-Gerin J.P., Fulop T. Age-related increased susceptibility of high-density lipoproteins (HDL) to in vitro oxidation induced by gamma-radiolysis of water. FEBS Lett 1998, 435:153-158.
14. Seres I., Paragh G., Deschene E., et al. Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp Gerontol 2004, 39:59-66.
15. Cherki M., Berrougui H., Isabelle M., et al. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging. Exp Gerontol 2007, 42:815-824.
16. Lescai F., Marchegiani F., Franceschi C. PON1 is a longevity gene: results of a meta-analysis. Ageing Res Rev 2009, 8:277-284.
17. Ahmad I., Narang R., Venkatraman A., et al. Two- and three-locus haplotypes of the paraoxonase (PON1) gene are associated with coronary heart disease in Asian Indians. Gene 2012, 506:242-247.
18. Durrington P.N., Mackness B., Mackness M.I. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001, 21:473-480.
19. La Du B.N., Aviram M., Billecke S., et al. On the physiological role(s) of the paraoxonases. Chem Biol Interact 1999, 119-120:379-388.
20. Tavori H., Aviram M., Khatib S., et al. Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic Biol Med 2009, 46:607-615.
21. Can Demirdöĝen B., Türkanoĝlu A., Bek S., et al. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke. Clin Biochem 2008, 41:1-9.
22. Bayrak A., Bayrak T., Demirpençe E., et al. Differential hydrolysis of homocysteine thiolactone by purified human serum (192)Q and (192)R PON1 isoenzymes. J Chromatogr B Analyt Technol Biomed Life Sci 2011, 879:49-55.
23. Ayub A., Mackness M.I., Arrol S., et al. Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 1999, 19:330-335.
24. Schnitzer E., Pinchuk I., Bor A., et al. Lipid oxidation in unfractionated serum and plasma. Chem Phys Lipids 1998, 92:151-170.
25. Szabo M.R., Iditoiu C., Chambre D., et al. Improved DPPH determination for antioxidant activity spectrophotometric assay. Chem Pap 2007, 61:214-216.
26. Li W.F., Furlong C.E., Costa L.G. Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol Lett 1995, 76:219-226.
27. Costa L.G., Vitalone A., Cole T.B., et al. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005, 69:541-550.
28. van Himbergen T.M., van der Schouw Y.T., Voorbij H.A., et al. Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women. Atherosclerosis 2008, 199:408-414.
29. Ozturk H., Gungor M., Yigit S., et al. Effect of exercise on the paraoxonase activity. Clin Biochem 2009, 42:343.
30. Marchegiani F., Marra M., Spazzafumo L., et al. Paraoxonase activity and genotype predispose to successful aging. J Gerontol A Biol Sci Med Sci 2006, 61:541-546.
31. Capri M., Salvioli S., Sevini F., et al. The genetics of human longevity. Ann NY Acad Sci 2006, 1067:252-263.
32. Miura Y., Sato Y., Arai Y., et al. Proteomic analysis of plasma proteins in Japanese semisuper centenarians. Exp Gerontol 2011, 46:81-85.
33. Berrougui H., Khalil A. Paraoxonase 1 promotes HDL-mediated cholesterol efflux. Importance of PON1 free sulfhydryls group. Chem Phys Lipids 2008, 154(suppl):S38.
34. van Himbergen T.M., van Tits L.J., Hectors M.P., et al. Paraoxonase-1 and linoleic acid oxidation in familial hypercholesterolemia. Biochem Biophys Res Commun 2005, 333:787-793.
35. Schiavon R., De Fanti E., Giavarina D., et al. Serum paraoxonase activity is decreased in uremic patients. Clin Chim Acta 1996, 247:71-80.
36. Tavori H., Aviram M., Khatib S., et al. Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284. Free Radic Biol Med 2011, 50:148-156.
37. Jaouad L., de Guise C., Berrougui H., et al. Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydryl groups. Atherosclerosis 2006, 185:191-200.
38. Ates O., Azizi S., Alp H.H., et al. Decreased serum paraoxonase 1 activity and increased serum homocysteine and malondialdehyde levels in age-related macular degeneration. Tohoku J Exp Med 2009, 217:17-22.
39. Stefanović A., Kotur-Stevuljević J., Spasić S., et al. HDL 2 Particles are associated with hyperglycaemia, lower PON1 activity and oxidative stress in type 2 diabetes mellitus patients. Clin Biochem 2010, 43:1230-1235.
40. Goswami B., Tayal D., Gupta N., et al. Paraoxonase: a multifaceted biomolecule. Clin Chim Acta 2009, 410:1-12.
41. Otero P., Herrera E., Bonet B. Dual effect of glucose on LDL oxidation: dependence on vitamin E. Free Radic Biol Med 2002, 33:1133-1140.
42. Schnitzer E., Pinchuk I., Bor A., et al. The effect of albumin on copper-induced LDL oxidation. Biochim Biophys Acta 1997, 1344:300-311.
43. Retsky K.L., Chen K., Zeind J., et al. Inhibition of copper-induced LDL oxidation by vitamin C is associated with decreased copper-binding to LDL and 2-oxo-histidine formation. Free Radic Biol Med 1999, 26:90-98.
44. 2+ mediated LDL oxidation. FEBS Lett 1997, 403:154-158.
45. Belinky P.A., Aviram M., Fuhrman B., et al. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis 1998, 137:49-61.
46. Corbo R.M., Ulizzi L., Piombo L., et al. Study on a possible effect of four longevity candidate genes (ACE, PON1, PPAR-gamma, and APOE) on human fertility. Biogerontology 2008, 9:317-323.